发明名称 Derivados bicíclicos de carboxamidas azabicíclicas, preparação dos mesmos e uso terapêutico dos mesmos
摘要 <p>Azabicyclic carboxamide compounds (I) and their acid or base addition salts, hydrates or solvates are new. Azabicyclic carboxamide compounds of formula (I) and their acid or base addition salts, hydrates or solvates are new. X 1-X 4N or CR 1; A : heteroaryl group; W 1O or S; n : 0-3; Y 1aryl or heteroaryl; and R 1e.g. H, halo, 1-6C alkyl, 3-7C cycloalkyl, 3-7C cycloalkyl-1-3C alkylene, 1-6C fluoroalkyl, aryloxy-1-6C alkyl or heteroaryloxy-1-6C alkyl. Full Definitions are given in the DEFINITIONS (Full Definitions) Field. An independent claim is included for the preparations of (I). [Image] ACTIVITY : Analgesic; Antiinflammatory; Metabolic; Gynecological; Gastrointestinal-Gen.; Respiratory-Gen.; Antipsoriatic; Antipruritic; Virucide; Neuroprotective; Antidepressant; Antiarthritic; Osteopathic; Muscular-Gen.; Antimigraine; Vulnerary; Dermatological; Cerebroprotective; Vasotropic; Antidiabetic; Uropathic; Nephrotropic; Antiulcer; Antiasthmatic; Antitussive; CNS-Gen.; Antiallergic; Immunosuppressive. MECHANISM OF ACTION : Transient receptor potential vanilloid type 1 (TRPV1) receptor modulator. The ability of (I) to inhibit current induced by capsaicin was tested in primary cells of dorsal root ganglia (DRG) of rat. The result showed that N-(2-hydroxymethyl-thiazolo[5,4-b]pyridin-6-yl)-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide (0.1 nM) exhibited 65.5% inhibition in DRG patch.</p>
申请公布号 BRPI0907628(A2) 申请公布日期 2015.07.21
申请号 BR2009PI07628 申请日期 2009.01.20
申请人 SANOFI-AVENTIS 发明人 LAURENT DUBOIS;YANNICK EVANNO;CATHERINE GILLE;ANDRÉ MALANDA
分类号 C07D401/12;A61K31/4365;A61K31/437;A61K31/47;A61P3/00;A61P11/00;A61P29/00;C07D471/04;C07D513/04 主分类号 C07D401/12
代理机构 代理人
主权项
地址